group | dose/μg・ml−1 | A | inhibition ratio/% |
medium control | - | 0.971 ± 0.062 | - |
DMSO control | - | 0.737 ± 0.041 | - |
TTE | 3.90625 μg・ml−1 | 0.744 ± 0.050 | −0.962 |
| 7.8125 μg・ml−1 | 0.707 ± 0.058 | 4.080 |
| 15.625 μg・ml−1 | 0.727 ± 0.079 | 1.381 |
| 31.25 μg・ml−1 | 0.657 ± 0.075 | 10.894 |
| 62.5 μg・ml−1 | 0.601 ± 0.104* | 18.436 |
| 125 μg・ml−1 | 0.359 ± 0.041*** | 51.373 |
| 250 μg・ml−1 | 0.328 ± 0.037*** | 55.478 |
| 500 μg・ml−1 | 0.281 ± 0.027*** | 61.846 |
| 1000 μg・ml−1 | 0.277 ± 0.025*** | 62.375 |
| 2000 μg・ml−1 | 0.110 ± 0.003*** | 85.128 |
medium control | - | 1.771 ± 0.160 | - |
DMSO control | - | 1.727 ± 0.094 | - |
triptolide | 3.90625 ng・ml−1 | 1.743 ± 0.069 | −0.897 |
| 7.8125 ng・ml−1 | 1.511 ± 0.125** | 12.508 |
| 15.625 ng・ml−1 | 1.388 ± 0.139*** | 19.639 |
| 31.25 ng・ml−1 | 1.002 ± 0.142*** | 42.011 |
| 62.5 ng・ml−1 | 0.997 ± 0.106*** | 42.282 |
| 125 ng・ml−1 | 0.736 ± 0.040*** | 57.407 |
| 250 ng・ml−1 | 0.584 ± 0.030*** | 66.214 |
| 500 ng・ml−1 | 0.572 ± 0.058*** | 66.861 |
| 1000 ng・ml−1 | 0.615 ± 0.056*** | 64.375 |
| 2000 ng・ml−1 | 0.592 ± 0.063*** | 65.705 |